
Abbott announced that it has entered an agreement to integrate data from its Libre CGM systems directly into Epic's electronic health record systems in the U.S. The collaboration aims to improve workflow efficiency for providers through Epic's Aura software, which brings health systems together with diagnostics labs and medical device manufacturers.
Through this integration, data from a user's LibreView account can be automatically linked to Epic, allowing clinicians to view their patients' glucose data within Epic before, during and after meeting with their patients. This process ensures healthcare providers can access key glucose data directly within their preferred workflows, enabling more informed care.
"Our goal is to simplify care and drive better outcomes for both providers and patients," said Lisa Earnhardt, executive vice president and group president of medical devices for Abbott. "While the integration with Libre data is Abbott's first medical device offering with Epic, it's just the beginning. We aim to expand this model to our other medical devices and connected care platforms in the future."
Now, more than 575,000 U.S. healthcare providers serving 280 million patients will have access to critical glucose data in their patients' charts, helping them spend less time finding data and more time on care management. With Libre systems and Epic, patients can more easily collaborate with their providers and utilize advanced CGM technology that can lead to improved patient engagement and behavior change.
"Our work with Abbott aims to make life simpler for the nearly 40 million people in the U.S. who live with diabetes today," said Alan Hutchison, vice president at Epic. "Diabetes requires close collaboration between patients, primary care providers, and specialists to manage a complex and time-critical care plan. This will help everyone focus more on patient care and less on administrative hurdles."